Normal view MARC view ISBD view

Economic Evaluation of Sevelamer versus Calcium-based Binders in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China.

Yang, Li

Economic Evaluation of Sevelamer versus Calcium-based Binders in Treating Hyperphosphatemia among Patients with End-stage Renal Disease in China. [electronic resource] - Clinical therapeutics Nov 2016 - 2459-2467.e1 p. digital

Publication Type: Comparative Study; Journal Article

ISSN: 1879-114X

Standard No.: 10.1016/j.clinthera.2016.09.012 doi

Subjects--Topical Terms:
Calcium--therapeutic use
Chelating Agents--therapeutic use
China
Cost-Benefit Analysis
Humans
Hyperphosphatemia--drug therapy
Kidney Failure, Chronic--therapy
Male
Quality-Adjusted Life Years
Sevelamer--therapeutic use
Survival Analysis

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)